Sudden Cardiac Death or Ventricular Arrythmia in Patients Taking Levetiracetam or Oxcarbazepine.

Madeline R CrossSamuel T SavitzLindsey R SangaralinghamElson L SoMichael J AckermanPeter A Noseworthy

Published in: Neurology (2024)

This study provides Class II evidence that sudden cardiac death and ventricular arrythmia are not more frequent in patients older than 17 years newly prescribed levetiracetam, compared with those prescribed oxcarbazepine.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
heart failure
prognostic factors
peritoneal dialysis
left ventricular
physical activity
patient reported